Abstract
Cellular communication network 2 (CCN2), also known as connective tissue growth factor (CTGF) regulates diverse cellular processes, some at odds with others, including adhesion, proliferation, apoptosis, and extracellular matrix (ECM) protein synthesis. Although a cause-and-effect relationship between CCN2/CTGF expression and local fibrotic reactions has initially been established, CCN2/CTGF manifests cell-, tissue-, and context-specific functions and differentially affects developmental and pathological processes ranging from progenitor cell fate decisions and angiogenesis to inflammation and tumorigenesis. CCN2/CTGF multimodular structure, binding to and activation or inhibition of multiple cell surface receptors, growth factors and ECM proteins, and susceptibility for proteolytic cleavage highlight the complexity to CCN2/CTGF biochemical attributes. CCN2/CTGF expression and dosage in the local environment affects a defined community of its interacting partners, and this results in sequestration of growth factors, interference with or potentiation of ligand-receptor binding, cellular internalization of CCN2/CTGF, inhibition or activation of proteases, and generation of CCN2/CTGF degradome products that add molecular diversity and expand the repertoire of functional modules in the cells and their microenvironment. Through these interactions, different intracellular signals and cellular responses are elicited culminating into physiological or pathological reactions. Thus, the CCN2/CTGF interactome is a defining factor of its tissue- and context-specific effects. Mapping of new CCN2/CTGF binding partners might shed light on yet unknown roles of CCN2/CTGF and provide a solid basis for tissue-specific targeting this molecule or its interacting partners in a therapeutic context.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abraham D (2008) Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc? Rheumatology (oxford) 47(Suppl 5):v8-9. https://doi.org/10.1093/rheumatology/ken278
Abreu JG, Ketpura NI, Reversade B, De Robertis EM (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4(8):599–604. https://doi.org/10.1038/ncb826
Al-Yozbaki M, Acha-Sagredo A, George A, Liloglou T, Wilson CM (2020) Balancing neurotrophin pathway and sortilin function: Its role in human disease. Biochim Biophys Acta Rev Cancer 1874(2):188429. https://doi.org/10.1016/j.bbcan.2020.188429
Aoyama E, Hattori T, Hoshijima M, Araki D, Nishida T, Kubota S et al (2009) N-terminal domains of CCN family 2/connective tissue growth factor bind to aggrecan. Biochem J 420(3):413–420. https://doi.org/10.1042/BJ20081991
Aoyama E, Kubota S, Takigawa M (2012) CCN2/CTGF binds to fibroblast growth factor receptor 2 and modulates its signaling. FEBS Lett 586(24):4270–4275. https://doi.org/10.1016/j.febslet.2012.10.038
Arndt-Jovin DJ, Botelho MG, Jovin TM (2014) Structure-function relationships of ErbB RTKs in the plasma membrane of living cells. Cold Spring Harb Perspect Biol 6(4):a008961. https://doi.org/10.1101/cshperspect.a008961
Arnott JA, Lambi AG, Mundy C, Hendesi H, Pixley RA, Owen TA et al (2011) The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit Rev Eukaryot Gene Expr 21(1):43–69. https://doi.org/10.1615/critreveukargeneexpr.v21.i1.40
Babic AM, Chen CC, Lau LF (1999) Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 19(4):2958–2966
Baeg GH, Lin X, Khare N, Baumgartner S, Perrimon N (2001) Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless. Development 128(1):87–94
Baguma-Nibasheka M, Kablar B (2008) Pulmonary hypoplasia in the connective tissue growth factor (Ctgf) null mouse. Dev Dyn 237(2):485–493. https://doi.org/10.1002/dvdy.21433
Bajpai AK, Davuluri S, Tiwary K, Narayanan S, Oguru S, Basavaraju K et al (2020) Systematic comparison of the protein-protein interaction databases from a user’s perspective. J Biomed Inform 103:103380. https://doi.org/10.1016/j.jbi.2020.103380
Ball DK, Rachfal AW, Kemper SA, Brigstock DR (2003) The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. J Endocrinol 176(2):R1-7. https://doi.org/10.1677/joe.0.176r001
Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16(5):585–601. https://doi.org/10.1111/j.1524-475X.2008.00410.x
Bishop JR, Schuksz M, Esko JD (2007) Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446(7139):1030–1037. https://doi.org/10.1038/nature05817
Bork P (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327(2):125–130. https://doi.org/10.1016/0014-5793(93)80155-n
Bornstein P, Sage EH (2002) Matricellular proteins: extracellular modulators of cell function. Curr Opin Cell Biol 14(5):608–616. https://doi.org/10.1016/s0955-0674(02)00361-7
Bornstein P, Kyriakides TR, Yang Z, Armstrong LC, Birk DE (2000) Thrombospondin 2 modulates collagen fibrillogenesis and angiogenesis. J Investig Dermatol Symp Proc 5(1):61–66. https://doi.org/10.1046/j.1087-0024.2000.00005.x
Brandan E, Cabello-Verrugio C, Vial C (2008) Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy. Matrix Biol 27(8):700–708. https://doi.org/10.1016/j.matbio.2008.07.004
Brigstock DR (1999) The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20(2):189–206. https://doi.org/10.1210/edrv.20.2.0360
Brigstock DR (2010) Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J Cell Commun Signal 4(1):1–4. https://doi.org/10.1007/s12079-009-0071-5
Butler GS, Overall CM (2009) Updated biological roles for matrix metalloproteinases and new “intracellular” substrates revealed by degradomics. Biochemistry 48(46):10830–10845. https://doi.org/10.1021/bi901656f
Butler GS, Dean RA, Morrison CJ, Overall CM (2010) Identification of cellular MMP substrates using quantitative proteomics: isotope-coded affinity tags (ICAT) and isobaric tags for relative and absolute quantification (iTRAQ). Methods Mol Biol 622:451–470. https://doi.org/10.1007/978-1-60327-299-5_26[doi]
Butler GS, Connor AR, Sounni NE, Eckhard U, Morrison CJ, Noel A et al (2017) Degradomic and yeast 2-hybrid inactive catalytic domain substrate trapping identifies new membrane-type 1 matrix metalloproteinase (MMP14) substrates: CCN3 (Nov) and CCN5 (WISP2). Matrix Biol 59:23–38. https://doi.org/10.1016/j.matbio.2016.07.006
Chaqour B (2013a) Molecular control of vascular development by the matricellular proteins CCN1 (Cyr61) and CCN2 (CTGF). Trends Dev Biol 7:59–72
Chaqour B (2013b) New Insights into the Function of the Matricellular CCN1: an Emerging Target in Proliferative Retinopathies. J Ophthalmic vis Res 8(1):77–82
Chaqour B (2020) Caught between a “Rho” and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness? J Cell Commun Signal 14(1):21–29. https://doi.org/10.1007/s12079-019-00529-3
Chaqour B, Goppelt-Struebe M (2006) Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins. FEBS J 273(16):3639–3649. https://doi.org/10.1111/j.1742-4658.2006.05360.x
Chaqour B, Yang R, Sha Q (2006) Mechanical stretch modulates the promoter activity of the profibrotic factor CCN2 through increased actin polymerization and NF-kappaB activation. J Biol Chem 281(29):20608–20622
Chen N, Chen CC, Lau LF (2000) Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans. J Biol Chem 275(32):24953–24961
Chen CC, Chen N, Lau LF (2001) The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem 276(13):10443–10452. https://doi.org/10.1074/jbc.M008087200
Chen CC, Kim KH, Lau LF (2016) The matricellular protein CCN1 suppresses hepatocarcinogenesis by inhibiting compensatory proliferation. Oncogene 35(10):1314–1323. https://doi.org/10.1038/onc.2015.190
Chiou MJ, Chao TT, Wu JL, Kuo CM, Chen JY (2006) The physiological role of CTGF/CCN2 in zebrafish notochond development and biological analysis of the proximal promoter region. Biochem Biophys Res Commun 349(2):750–758. https://doi.org/10.1016/j.bbrc.2006.08.095
Chowdhury I, Chaqour B (2004) Regulation of connective tissue growth factor (CTGF/CCN2) gene transcription and mRNA stability in smooth muscle cells. Involvement of RhoA GTPase and p38 MAP kinase and sensitivity to actin dynamics. Eur J Biochem 271(22): 4436–4450. doi:https://doi.org/10.1111/j.1432-1033.2004.04382.x.
Chu CY, Chang CC, Prakash E, Kuo ML (2008) Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 15(6):675–685. https://doi.org/10.1007/s11373-008-9264-9
Cicha I, Yilmaz A, Klein M, Raithel D, Brigstock DR, Daniel WG et al (2005) Connective tissue growth factor is overexpressed in complicated atherosclerotic plaques and induces mononuclear cell chemotaxis in vitro. Arterioscler Thromb Vasc Biol 25(5):1008–1013. https://doi.org/10.1161/01.ATV.0000162173.27682.7b
Daly NL, Craik DJ (2011) Bioactive cystine knot proteins. Curr Opin Chem Biol 15(3):362–368. https://doi.org/10.1016/j.cbpa.2011.02.008
Darland DC, Cain JT, Berosik MA, Saint-Geniez M, Odens PW, Schaubhut GJ et al (2011) Vascular endothelial growth factor (VEGF) isoform regulation of early forebrain development. Dev Biol 358(1):9–22. https://doi.org/10.1016/j.ydbio.2011.06.045
Dean RA, Butler GS, Hamma-Kourbali Y, Delbe J, Brigstock DR, Courty J et al (2007) Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis. Mol Cell Biol 27(24):8454–8465. https://doi.org/10.1128/Mcb.00821-07
di Mola FF, Di Sebastiano P, Gardini A, Hartel M, Buchler MW, Friess H et al (2003) Expression of connective tissue growth factor (CTGF) in pancreatic cancer. Tumori 89(4 Suppl):58–59
Doherty HE, Kim HS, Hiller S, Sulik KK, Maeda N (2010) A Mouse Strain Where Basal Connective Tissue Growth Factor Gene Expression Can Be Switched from Low to High. PLoS ONE 5(9):e12909. https://doi.org/10.1371/journal.pone.0012909
Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C et al (2011) Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 103(15):1162–1178. https://doi.org/10.1093/jnci/djr224
Fadic R, Mezzano V, Alvarez K, Cabrera D, Holmgren J, Brandan E (2006) Increase in decorin and biglycan in Duchenne Muscular Dystrophy: role of fibroblasts as cell source of these proteoglycans in the disease. J Cell Mol Med 10(3):758–769. https://doi.org/10.1111/j.1582-4934.2006.tb00435.x
Faherty N, Curran SP, O’Donovan H, Martin F, Godson C, Brazil DP et al (2012) CCN2/CTGF increases expression of miR-302 microRNAs, which target the TGFbeta type II receptor with implications for nephropathic cell phenotypes. J Cell Sci 125(Pt 23):5621–5629. https://doi.org/10.1242/jcs.105528
Fahey ME, Bennett MJ, Mahon C, Jager S, Pache L, Kumar D et al (2011) GPS-Prot: a web-based visualization platform for integrating host-pathogen interaction data. BMC Bioinform 12:298. https://doi.org/10.1186/1471-2105-12-298
Fontes MS, Kessler EL, van Stuijvenberg L, Brans MA, Falke LL, Kok B et al (2015) CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload. J Mol Cell Cardiol 88:82–90. https://doi.org/10.1016/j.yjmcc.2015.09.015
Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107(3):404–411. https://doi.org/10.1111/1523-1747.ep12363389
Fudalej E, Justyniarska M, Kasarello K, Dziedziak J, Szaflik JP, Cudnoch-Jedrzejewska A (2021) Neuroprotective factors of the retina and their role in promoting survival of retinal ganglion cells: a review. Ophthalmic Res 64(3):345–355. https://doi.org/10.1159/000514441
Gao RP, Brigstock DR (2003) Low density lipoprotein receptor-related protein (LRP) is a heparin-dependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 27(3):214–220. https://doi.org/10.1016/S1386-6346(03)00241-9
Gao R, Brigstock DR (2004) Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279(10):8848–8855. https://doi.org/10.1074/jbc.M313204200
Gao R, Brigstock DR (2005) Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor. Gastroenterology 129(3):1019–1030
Gerritsen KG, Falke LL, van Vuuren SH, Leeuwis JW, Broekhuizen R, Nguyen TQ et al (2016) Plasma CTGF is independently related to an increased risk of cardiovascular events and mortality in patients with atherosclerotic disease: the SMART study. Growth Factors 34(3–4):149–158. https://doi.org/10.1080/08977194.2016.1210142
Gibson DJ, Pi L, Sriram S, Mao C, Petersen BE, Scott EW et al (2014) Conditional knockout of CTGF affects corneal wound healing. Invest Ophthalmol vis Sci 55(4):2062–2070. https://doi.org/10.1167/iovs.13-12735
Gravning J, Orn S, Kaasboll OJ, Martinov VN, Manhenke C, Dickstein K et al (2012) Myocardial connective tissue growth factor (CCN2/CTGF) attenuates left ventricular remodeling after myocardial infarction. PLoS ONE 7(12):e52120. https://doi.org/10.1371/journal.pone.0052120
Grotendorst GR, Duncan MR (2005) Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 19(7):729–738. https://doi.org/10.1096/fj.04-3217com
Grunert M, Nurcombe V, Cool SM (2008) Stem cell fate decisions: the role of heparan sulfate in the control of autocrine and paracrine signals. Curr Stem Cell Res Ther 3(1):1–8. https://doi.org/10.2174/157488808783489417
Guillon-Munos A, Oikonomopoulou K, Michel N, Smith CR, Petit-Courty A, Canepa S et al (2011) Kallikrein-related peptidase 12 hydrolyzes matricellular proteins of the CCN family and modifies interactions of CCN1 and CCN5 with growth factors. J Biol Chem 286(29):25505–25518. https://doi.org/10.1074/jbc.M110.213231
Guo CM, Wang YS, Hu D, Han QH, Wang JB, Hou X et al (2009) Modulation of migration and Ca2+ signaling in retinal pigment epithelium cells by recombinant human CTGF. Curr Eye Res 34(10):852–862. https://doi.org/10.3109/02713680903128935
Harper JR, Spiro RC, Gaarde WA, Tamura RN, Pierschbacher MD, Noble NA et al (1994) Role of transforming growth factor beta and decorin in controlling fibrosis. Methods Enzymol 245:241–254. https://doi.org/10.1016/0076-6879(94)45014-5
Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y (2002) Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 277(39):36288–36295. https://doi.org/10.1074/jbc.M201674200
Hausser HJ, Decking R, Brenner RE (2004) Testican-1, an inhibitor of pro-MMP-2 activation, is expressed in cartilage. Osteoarth Cartilage 12(11):870–877. https://doi.org/10.1016/j.joca.2004.07.008
Hendesi H, Barbe MF, Safadi FF, Monroy MA, Popoff SN (2015) Integrin mediated adhesion of osteoblasts to connective tissue growth factor (CTGF/CCN2) induces cytoskeleton reorganization and cell differentiation. PLoS ONE 10(2):e0115325. https://doi.org/10.1371/journal.pone.0115325
Heng EC, Huang Y, Black SA Jr, Trackman PC (2006) CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins. J Cell Biochem 98(2):409–420. https://doi.org/10.1002/jcb.20810
Hinton DR, He S, Jin ML, Barron E, Ryan SJ (2002) Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye (lond) 16(4):422–428. https://doi.org/10.1038/sj.eye.6700190
Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33(10):461–473. https://doi.org/10.1016/j.tibs.2008.07.006
Hoshijima M, Hattori T, Inoue M, Araki D, Hanagata H, Miyauchi A et al (2006) CT domain of CCN2/CTGF directly interacts with fibronectin and enhances cell adhesion of chondrocytes through integrin alpha5beta1. FEBS Lett 580(5):1376–1382. https://doi.org/10.1016/j.febslet.2006.01.061
Hoshijima M, Hattori T, Aoyama E, Nishida T, Yamashiro T, Takigawa M (2012) Roles of heterotypic CCN2/CTGF-CCN3/NOV and homotypic CCN2-CCN2 interactions in expression of the differentiated phenotype of chondrocytes. FEBS J 279(19):3584–3597. https://doi.org/10.1111/j.1742-4658.2012.08717.x
Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J et al (2015) The BioPlex network: a systematic exploration of the human interactome. Cell 162(2):425–440. https://doi.org/10.1016/j.cell.2015.06.043
Huttlin EL, Bruckner RJ, Navarrete-Perea J, Cannon JR, Baltier K, Gebreab F, et al (2021) Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184(11): 3022–3040 e3028. doi: https://doi.org/10.1016/j.cell.2021.04.011.
Inoki I, Shiomi T, Hashimoto G, Enomoto H, Nakamura H, Makino K et al (2002) Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis. FASEB J 16(2):219–221. https://doi.org/10.1096/fj.01-0332fje
Iozzo RV (2005) Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 6(8):646–656. https://doi.org/10.1038/nrm1702
Ivkovic S, Yoon BS, Popoff SN, Safadi FF, Libuda DE, Stephenson RC et al (2003) Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development. Development 130(12):2779–2791. https://doi.org/10.1242/dev.00505
Iyer S, Acharya KR (2011) Tying the knot: the cystine signature and molecular-recognition processes of the vascular endothelial growth factor family of angiogenic cytokines. FEBS J 278(22):4304–4322. https://doi.org/10.1111/j.1742-4658.2011.08350.x
Jarvelainen H, Sainio A, Wight TN (2015) Pivotal role for decorin in angiogenesis. Matrix Biol 43:15–26. https://doi.org/10.1016/j.matbio.2015.01.023
Jedsadayanmata A, Chen CC, Kireeva ML, Lau LF, Lam SCT (1999) Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3). J Biol Chem 274(34):24321–24327. https://doi.org/10.1074/jbc.274.34.24321
Jefferson T, Auf dem Keller U, Bellac C, Metz VV, Broder C, Hedrich J et al (2013) The substrate degradome of meprin metalloproteases reveals an unexpected proteolytic link between meprin beta and ADAM10. Cell Mol Life Sci 70(2):309–333. https://doi.org/10.1007/s00018-012-1106-2
Ji W, Zhu P, Liang R, Zhang L, Zhang Y, Wang Y et al (2021) Coxsackievirus A2 leads to heart injury in a neonatal mouse model. Viruses. https://doi.org/10.3390/v13081588
Jun JI, Kim KH, Lau LF (2015) The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing. Nat Commun 6:7386. https://doi.org/10.1038/ncomms8386
Kaasboll OJ, Moe IT, Ahmed MS, Stang E, Hagelin EM, Attramadal H (2016) CTGF/CCN2 postconditioning increases tolerance of murine hearts towards ischemia-reperfusion injury. PLoS ONE 11(2):e0149000. https://doi.org/10.1371/journal.pone.0149000
Kaasboll OJ, Gadicherla AK, Wang JH, Monsen VT, Hagelin EMV, Dong MQ et al (2018) Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation. J Biol Chem 293(46):17953–17970. https://doi.org/10.1074/jbc.RA118.004559
Kawata K, Kubota S, Eguchi T, Aoyama E, Moritani NH, Kondo S et al (2012) Role of LRP1 in transport of CCN2 protein in chondrocytes. J Cell Sci 125(Pt 12):2965–2972. https://doi.org/10.1242/jcs.101956
Khattab HM, Aoyama E, Kubota S, Takigawa M (2015) Physical interaction of CCN2 with diverse growth factors involved in chondrocyte differentiation during endochondral ossification. J Cell Commun Signal 9(3):247–254. https://doi.org/10.1007/s12079-015-0290-x
Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, Abler AS et al (1997) Cyr61 and Fisp12 are both ECM-associated signaling molecules: Activities, metabolism, and localization during development. Exp Cell Res 233(1):63–77. https://doi.org/10.1006/excr.1997.3548
Kitisin K, Saha T, Blake T, Golestaneh N, Deng M, Kim C et al (2007) Tgf-Beta signaling in development. Sci STKE. https://doi.org/10.1126/stke.3992007cm1
Klaassen I, van Geest RJ, Kuiper EJ, van Noorden CJ, Schlingemann RO (2015) The role of CTGF in diabetic retinopathy. Exp Eye Res 133:37–48. https://doi.org/10.1016/j.exer.2014.10.016
Kothapalli D, Hayashi N, Grotendorst GR (1998) Inhibition of TGF-beta-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle. FASEB J 12(12):1151–1161. https://doi.org/10.1096/fasebj.12.12.1151
Krupska I, Bruford EA, Chaqour B (2015) Eyeing the Cyr61/CTGF/NOV (CCN) group of genes in development and diseases: highlights of their structural likenesses and functional dissimilarities. Hum Genomics 9(1):24. https://doi.org/10.1186/s40246-015-0046-y
Kubota S, Takigawa M (2015) Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. Clin Sci (lond) 128(3):181–196. https://doi.org/10.1042/CS20140264
Kubota S, Kawata K, Yanagita T, Doi H, Kitoh T, Takigawa M (2004) Abundant retention and release of connective tissue growth factor (CTGF/CCN2) by platelets. J Biochem 136(3):279–282. https://doi.org/10.1093/jb/mvh126
Kubota S, Kawaki H, Kondo S, Yosimichi G, Minato M, Nishida T et al (2006) Multiple activation of mitogen-activated protein kinases by purified independent CCN2 modules in vascular endothelial cells and chondrocytes in culture. Biochimie 88(12):1973–1981. https://doi.org/10.1016/j.biochi.2006.07.007
Kuiper EJ, Van Nieuwenhoven FA, de Smet MD, van Meurs JC, Tanck MW, Oliver N et al (2008) The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE 3(7):e2675. https://doi.org/10.1371/journal.pone.0002675
Kyriakides TR, Bornstein P (2003) Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost 90(6):986–992. https://doi.org/10.1160/Th03-06-0399
Lachowski D, Cortes E, Rice A, Pinato D, Rombouts K, Del Rio Hernandez A (2019) Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis. Sci Rep 9(1):7299. https://doi.org/10.1038/s41598-019-43759-6
Laronha H, Carpinteiro I, Portugal J, Azul A, Polido M, Petrova KT et al (2020) Challenges in matrix metalloproteinases inhibition. Biomolecules. https://doi.org/10.3390/biom10050717
Lau LF, Lam SC (1999) The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 248(1):44–57. https://doi.org/10.1006/excr.1999.4456
Leask A (2008) CCN2 YAPs at cancer. J Cell Commun Signal 2(1–2):47–48. https://doi.org/10.1007/s12079-008-0027-1
Leask A (2017) CCN2 in skin fibrosis. Methods Mol Biol 1489:417–421. https://doi.org/10.1007/978-1-4939-6430-7_34
Leask A, Abraham DJ (2006) All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119(23):4803–4810. https://doi.org/10.1242/jcs.03270
Leask A, Parapuram SK, Shi-Wen X, Abraham DJ (2009) Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal 3(2):89–94. https://doi.org/10.1007/s12079-009-0037-7
Leask A, Holmes A, Black CM, Abraham DJ (2003) Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278(15):13008–13015. https://doi.org/10.1074/jbc.M210366200
Lee S, Elaskandrany M, Ahad A, Chaqour B (2017) Analysis of CCN protein expression and activities in vasoproliferative retinopathies. Methods Mol Biol 1489:543–556. https://doi.org/10.1007/978-1-4939-6430-7_46
Li C, Zhen G, Chai Y, Xie L, Crane JL, Farber E et al (2016) RhoA determines lineage fate of mesenchymal stem cells by modulating CTGF-VEGF complex in extracellular matrix. Nat Commun 7:11455. https://doi.org/10.1038/ncomms11455
Liu H, Yang R, Tinner B, Choudhry A, Schutze N, Chaqour B (2008) Cysteine-rich protein 61 and connective tissue growth factor induce deadhesion and anoikis of retinal pericytes. Endocrinology 149(4):1666–1677. https://doi.org/10.1210/en.2007-1415
Maeda A, Nishida T, Aoyama E, Kubota S, Lyons KM, Kuboki T et al (2009) CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem 145(2):207–216. https://doi.org/10.1093/jb/mvn159
Mahajan D, Kancharla S, Kolli P, Sharma AK, Singh S, Kumar S et al (2021) Role of fibulins in embryonic stage development and their involvement in various diseases. Biomolecules. https://doi.org/10.3390/biom11050685
Mahley RW, Ji ZS (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40(1):1–16
Mendes FA, Coelho Aguiar JM, Kahn SA, Reis AH, Dubois LG, Romao LF et al (2015) Connective-tissue growth factor (CTGF/CCN2) Induces astrogenesis and fibronectin expression of embryonic neural cells in vitro. PLoS ONE 10(8):e0133689. https://doi.org/10.1371/journal.pone.0133689
Mercurio S, Latinkic B, Itasaki N, Krumlauf R, Smith JC (2004) Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 131(9):2137–2147. https://doi.org/10.1242/dev.01045
Miranti CK, Brugge JS (2002) Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4(4):E83-90. https://doi.org/10.1038/ncb0402-e83
Mochizuki S, Tanaka R, Shimoda M, Onuma J, Fujii Y, Jinno H et al (2010) Connective tissue growth factor is a substrate of ADAM28. Biochem Biophys Res Commun 402(4):651–657. https://doi.org/10.1016/j.bbrc.2010.10.077
Mohiuddin M, Lopez G, Sinon J, Hartnett ME, Bulakhova A, Chaqour B (2021) Regulation of neurogenesis and gliogenesis by the matricellular protein CCN2/CTGF in the Mouse Retina. PNAS (Under Review)
Mokalled MH, Patra C, Dickson AL, Endo T, Stainier DY, Poss KD (2016) Injury-induced ctgfa directs glial bridging and spinal cord regeneration in zebrafish. Science 354(6312):630–634. https://doi.org/10.1126/science.aaf2679
Moon S, Lee S, Caesar JA, Pruchenko S, Leask A, Knowles JA et al (2020) A CTGF-YAP regulatory pathway is essential for angiogenesis and barriergenesis in the retina. Iscience. https://doi.org/10.1016/j.isci.2020.101184
Muratoglu SC, Belgrave S, Hampton B, Migliorini M, Coksaygan T, Chen L et al (2013) LRP1 protects the vasculature by regulating levels of connective tissue growth factor and HtrA1. Arterioscler Thromb Vasc Biol 33(9):2137–2146. https://doi.org/10.1161/ATVBAHA.113.301893
Murphy-Ullrich JE, Sage EH (2014) Revisiting the matricellular concept. Matrix Biol 37:1–14. https://doi.org/10.1016/j.matbio.2014.07.005
Nagashima T, Kim J, Li Q, Lydon JP, DeMayo FJ, Lyons KM et al (2011) Connective tissue growth factor is required for normal follicle development and ovulation. Mol Endocrinol 25(10):1740–1759. https://doi.org/10.1210/me.2011-1045
Nguyen TQ, Roestenberg P, van Nieuwenhoven FA, Bovenschen N, Li Z, Xu L et al (2008) CTGF inhibits BMP-7 signaling in diabetic nephropathy. J Am Soc Nephrol 19(11):2098–2107. https://doi.org/10.1681/ASN.2007111261
Nickel J, Ten Dijke P, Mueller TD (2018) TGF-beta family co-receptor function and signaling. Acta Biochim Biophys Sin (shanghai) 50(1):12–36. https://doi.org/10.1093/abbs/gmx126
Nishida T, Kubota S, Fukunaga T, Kondo S, Yosimichi G, Nakanishi T et al (2003) CTGF/Hcs24, hypertrophic chondrocyte-specific gene product, interacts with perlecan in regulating the proliferation and differentiation of chondrocytes. J Cell Physiol 196(2):265–275. https://doi.org/10.1002/jcp.10277
Nishida T, Maeda A, Kubota S, Takigawa M (2008) Role of mechanical-stress inducible protein Hcs24/CTGF/CCN2 in cartilage growth and regeneration: mechanical stress induces expression of Hcs24/CTGF/CCN2 in a human chondrocytic cell line HCS-2/8, rabbit costal chondrocytes and meniscus tissue cells. Biorheology 45(3–4):289–299
Nishida T, Kubota S, Aoyama E, Janune D, Maeda A, Takigawa M (2011) Effect of CCN2 on FGF2-induced proliferation and MMP9 and MMP13 productions by chondrocytes. Endocrinology 152(11):4232–4241. https://doi.org/10.1210/en.2011-0234
O’Donovan HC, Hickey F, Brazil DP, Kavanagh DH, Oliver N, Martin F et al (2012) Connective tissue growth factor antagonizes transforming growth factor-beta1/Smad signalling in renal mesangial cells. Biochem J 441(1):499–510. https://doi.org/10.1042/BJ20110910
Perbal B (2004) CCN proteins: multifunctional signalling regulators. Lancet 363(9402):62–64. https://doi.org/10.1016/S0140-6736(03)15172-0
Perbal B, Martinerie C, Sainson R, Werner M, He B, Roizman B (1999) The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci USA 96(3):869–874. https://doi.org/10.1073/pnas.96.3.869
Petrosino JM, Leask A, Accornero F (2019) Genetic manipulation of CCN2/CTGF unveils cell-specific ECM-remodeling effects in injured skeletal muscle. FASEB J 33(2):2047–2057. https://doi.org/10.1096/fj.201800622RR
Pi L, Ding X, Jorgensen M, Pan JJ, Oh SH, Pintilie D et al (2008) Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation. Hepatology 47(3):996–1004. https://doi.org/10.1002/hep.22079
Pi L, Shenoy AK, Liu J, Kim S, Nelson N, Xia H et al (2012) CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J 26(8):3365–3379. https://doi.org/10.1096/fj.11-200154
Plow EF, Haas TA, Zhang L, Loftus J, Smith JW (2000) Ligand binding to integrins. J Biol Chem 275(29):21785–21788. https://doi.org/10.1074/jbc.R000003200
Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, Diez RRR, Mas S, Lavoz C et al (2013) Connective tissue growth factor is a new ligand of epidermal growth factor receptor. J Mol Cell Biol 5(5):323–335. https://doi.org/10.1093/jmcb/mjt030
Rayego-Mateos S, Morgado-Pascual JL, Rodrigues-Diez RR, Rodrigues-Diez R, Falke LL, Mezzano S et al (2018a) Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation. J Pathol 244(2):227–241. https://doi.org/10.1002/path.5007
Rayego-Mateos S, Rodrigues-Diez R, Morgado-Pascual JL, Valentijn F, Valdivielso JM, Goldschmeding R et al (2018b) Role of epidermal growth factor receptor (EGFR) and its ligands in kidney inflammation and damage. Mediators Inflamm 2018:8739473. https://doi.org/10.1155/2018/8739473
Reed CC, Iozzo RV (2002) The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J 19(4–5):249–255. https://doi.org/10.1023/A:1025383913444
Rinne SS, Orlova A, Tolmachev V (2021) PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology. Int J Mol Sci. https://doi.org/10.3390/ijms22073663
Rodrigues-Diez RR, Garcia-Redondo AB, Orejudo M, Rodrigues-Diez R, Briones AM, Bosch-Panadero E et al (2015) The C-terminal module IV of connective tissue growth factor, through EGFR/Nox1 signaling, activates the NF-kappaB pathway and proinflammatory factors in vascular smooth muscle cells. Antioxid Redox Signal 22(1):29–47. https://doi.org/10.1089/ars.2013.5500
Sarrazin S, Lamanna WC, Esko JD (2011) Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. https://doi.org/10.1101/cshperspect.a004952
Schober JM, Chen NY, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP et al (2002) Identification of integrin alpha(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 99(12):4457–4465. https://doi.org/10.1182/blood.V99.12.4457
Schwarz E (2017) Cystine knot growth factors and their functionally versatile proregions. Biol Chem 398(12):1295–1308. https://doi.org/10.1515/hsz-2017-0163
Seetharaman S, Etienne-Manneville S (2018) Integrin diversity brings specificity in mechanotransduction. Biol Cell 110(3):49–64. https://doi.org/10.1111/boc.201700060
Segarini PR, Nesbitt JE, Li D, Hays LG, Yates JR III, Carmichael DF (2001) The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 276(44):40659–40667
Shi P, Chen H, Cho MR, Stroscio MA (2006) Peptide-directed binding of quantum dots to integrins in human fibroblast. IEEE Trans Nanobiosci 5(1):15–19. https://doi.org/10.1109/tnb.2005.864014
Shimo T, Koyama E, Sugito H, Wu C, Shimo S, Pacifici M (2005) Retinoid signaling regulates CTGF expression in hypertrophic chondrocytes with differential involvement of MAP kinases. J Bone Miner Res 20(5):867–877. https://doi.org/10.1359/JBMR.041235
Siemerink MJ, Klaassen I, Van Noorden CJ, Schlingemann RO (2013) Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy. J Histochem Cytochem 61(2):101–115. https://doi.org/10.1369/0022155412467635
Sivan SS, Wachtel E, Roughley P (2014) Structure, function, aging and turnover of aggrecan in the intervertebral disc. Biochim Biophys Acta 1840(10):3181–3189. https://doi.org/10.1016/j.bbagen.2014.07.013
Tsai HC, Su HL, Huang CY, Fong YC, Hsu CJ, Tang CH (2014) CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d. Oncotarget 5(11):3800–3812. https://doi.org/10.18632/oncotarget.1998
Vial C, Gutierrez J, Santander C, Cabrera D, Brandan E (2011) Decorin interacts with connective tissue growth factor (CTGF)/CCN2 by LRR12 inhibiting its biological activity. J Biol Chem 286(27):24242–24252. https://doi.org/10.1074/jbc.M110.189365
Vitt UA, Hsu SY, Hsueh AJ (2001) Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Mol Endocrinol 15(5):681–694. https://doi.org/10.1210/mend.15.5.0639
Wahab NA, Weston BS, Mason RM (2005) Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 16(2):340–351. https://doi.org/10.1681/ASN.2003100905
Wang X, McLennan SV, Allen TJ, Tsoutsman T, Semsarian C, Twigg SM (2009) Adverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factor. Am J Physiol Cell Physiol 297(6):C1490-1500. https://doi.org/10.1152/ajpcell.00049.2009
Wang X, McLennan SV, Allen TJ, Twigg SM (2010) Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes. J Cell Commun Signal 4(1):15–23. https://doi.org/10.1007/s12079-009-0083-1
Wegener KL, Campbell ID (2008) Transmembrane and cytoplasmic domains in integrin activation and protein-protein interactions (review). Mol Membr Biol 25(5):376–387. https://doi.org/10.1080/09687680802269886
Weinbaum JS, Tranquillo RT, Mecham RP (2010) The matrix-binding domain of microfibril-associated glycoprotein-1 targets active connective tissue growth factor to a fibroblast-produced extracellular matrix. Macromol Biosci 10(11):1338–1344. https://doi.org/10.1002/mabi.201000121
Whitson RJ, Lucia MS, Lambert JR (2013) Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2). J Cell Biochem 114(6):1424–1433. https://doi.org/10.1002/jcb.24484
Yoshida K, Munakata H (2007) Connective tissue growth factor binds to fibronectin through the type I repeat modules and enhances the affinity of fibronectin to fibrin. Biochim Biophys Acta 1770(4):672–680. https://doi.org/10.1016/j.bbagen.2006.11.010
Yosimichi G, Kubota S, Nishida T, Kondo S, Yanagita T, Nakao K et al (2006) Roles of PKC, PI3K and JNK in multiple transduction of CCN2/CTGF signals in chondrocytes. Bone 38(6):853–863. https://doi.org/10.1016/j.bone.2005.11.016
Yu IS, Chang HC, Chen KC, Lu YL, Shy HT, Chen CY et al (2019) Genetic elimination of connective tissue growth factor in the forebrain affects subplate neurons in the cortex and oligodendrocytes in the underlying white matter. Front Neuroanat 13:16. https://doi.org/10.3389/fnana.2019.00016
Zhang H, Pasolli HA, Fuchs E (2011) Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci U S A 108(6):2270–2275. https://doi.org/10.1073/pnas.1019603108
Zhang W, Ge Y, Cheng Q, Zhang Q, Fang L, Zheng J (2018) Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment. Oncotarget 9(4):5480–5491. https://doi.org/10.18632/oncotarget.23869
Zhen Y, Ye Y, Yu X, Mai C, Zhou Y, Chen Y et al (2014) Reduced CTGF expression promotes cell growth, migration, and invasion in nasopharyngeal carcinoma. PLoS ONE 8(6):e64976. https://doi.org/10.1371/journal.pone.0064976
Funding
This work was supported in part by a grant from the National Eye Institute of the National Institutes of Health (EY024998) to B.C.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Authors have no relevant financial or non-financial interest to disclose.
Consent for Publication
Yes.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zaykov, V., Chaqour, B. The CCN2/CTGF interactome: an approach to understanding the versatility of CCN2/CTGF molecular activities. J. Cell Commun. Signal. 15, 567–580 (2021). https://doi.org/10.1007/s12079-021-00650-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-021-00650-2